Innovation in Photon Therapy^TM

Immuno-Genic Corporation envisions providing the technology that will change the basis of medical service delivery and the perception of therapeutic treatment modalities worldwide. The Ig2000 will be known as the combination device breakthrough that brought together physics and biotech through a light source that will shine around the world. We intend for the Ig2000 biomodulation technology to enhance the health care delivery system moving it away from the traditional pharmaceutical treatment therapies to one of the biomodulation alternatives and/or as an adjunctive therapy attained through the use of our proprietary patented technology.

Please review the information currently available on the web site. If you have any questions, please contact us.